Literature DB >> 21353445

Interim methadone treatment compared to standard methadone treatment: 4-month findings.

Robert P Schwartz1, Sharon M Kelly, Kevin E O'Grady, Devang Gandhi, Jerome H Jaffe.   

Abstract

Interim methadone (IM; with emergency counseling only) is an effective but highly restricted alternative to methadone treatment program (MTP) waiting lists. However, it is not known whether IM disadvantages patients as compared with standard methadone treatment (SM). In this clinical trial, conducted in two MTPs, 230 newly admitted patients were randomly assigned to IM, SM, and "restored" methadone treatment (SM with a counselor with a reduced caseload). Data were analyzed using generalized estimating equations and generalized linear modeling. There were no significant differences among conditions in days in treatment or of heroin or cocaine use and heroin- or cocaine-positive urine drug tests. The IM as compared to the SM group had significantly fewer self-reported days of criminal activity and lower amounts of money spent on drugs and illegal income. These findings suggest that when SM is unavailable, IM should be more widely used and less restricted.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21353445      PMCID: PMC3110526          DOI: 10.1016/j.jsat.2011.01.008

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  16 in total

1.  The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).

Authors:  Maree Teesson; Katherine Mills; Joanne Ross; Shane Darke; Anna Williamson; Alys Havard
Journal:  Addiction       Date:  2007-11-08       Impact factor: 6.526

2.  Contingency management of urinalysis results and intensity of counseling services have an interactive impact on methadone maintenance treatment outcome.

Authors:  D A Calsyn; E A Wells; A J Saxon; T R Jackson; A F Wrede; V Stanton; C Fleming
Journal:  J Addict Dis       Date:  1994

3.  Treatment Outcome Prospective Study (TOPS): client characteristics and behaviors before, during, and after treatment.

Authors:  R L Hubbard; J V Rachal; S G Craddock; E R Cavanaugh
Journal:  NIDA Res Monogr       Date:  1984

4.  Drug abuse treatment process components that improve retention.

Authors:  D D Simpson; G W Joe; G A Rowan-Szal; J M Greener
Journal:  J Subst Abuse Treat       Date:  1997 Nov-Dec

5.  A randomized controlled trial of interim methadone maintenance.

Authors:  Robert P Schwartz; David A Highfield; Jerome H Jaffe; Joseph V Brady; Carol B Butler; Charles O Rouse; Jason M Callaman; Kevin E O'Grady; Robert J Battjes
Journal:  Arch Gen Psychiatry       Date:  2006-01

6.  Methadone treatment for opiate dependent patients in general practice and specialist clinic settings: Outcomes at 2-year follow-up.

Authors:  Michael Gossop; Duncan Stewart; Nadine Browne; John Marsden
Journal:  J Subst Abuse Treat       Date:  2003-06

7.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992

8.  One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects.

Authors:  K M Carroll; B J Rounsaville; C Nich; L T Gordon; P W Wirtz; F Gawin
Journal:  Arch Gen Psychiatry       Date:  1994-12

9.  The effects of psychosocial services in substance abuse treatment.

Authors:  A T McLellan; I O Arndt; D S Metzger; G E Woody; C P O'Brien
Journal:  JAMA       Date:  1993-04-21       Impact factor: 56.272

10.  Scaling-up interim methadone maintenance: treatment for 1,000 heroin-addicted individuals.

Authors:  Robert P Schwartz; Jerome H Jaffe; Kevin E O'Grady; Babita Das; David A Highfield; Monique E Wilson
Journal:  J Subst Abuse Treat       Date:  2009-06-21
View more
  21 in total

Review 1.  Retention in medication-assisted treatment for opiate dependence: A systematic review.

Authors:  Christine Timko; Nicole R Schultz; Michael A Cucciare; Lisa Vittorio; Christina Garrison-Diehn
Journal:  J Addict Dis       Date:  2015-10-14

2.  Interim treatment: Bridging delays to opioid treatment access.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2015-04-30       Impact factor: 4.018

3.  A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment.

Authors:  Michael S Gordon; Frank J Vocci; Faye Taxman; Marc Fishman; Bikash Sharma; Thomas R Blue; Kevin E O'Grady
Journal:  Contemp Clin Trials       Date:  2019-02-20       Impact factor: 2.226

4.  Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial.

Authors:  Robert P Schwartz; Sharon M Kelly; Shannon G Mitchell; Laura Dunlap; Gary A Zarkin; Anjalee Sharma; Kevin E O'Grady; Jerome H Jaffe
Journal:  Contemp Clin Trials       Date:  2016-06-07       Impact factor: 2.226

5.  When Added to Opioid Agonist Treatment, Psychosocial Interventions do not Further Reduce the Use of Illicit Opioids: A Comment on Dugosh et al.

Authors:  Robert P Schwartz
Journal:  J Addict Med       Date:  2016 Jul-Aug       Impact factor: 3.702

6.  Impact of methadone with versus without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trial.

Authors:  Sharon M Kelly; Robert P Schwartz; Kevin E Oʼgrady; Devang Gandhi; Jerome H Jaffe
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

7.  Patterns in admission delays to outpatient methadone treatment in the United States.

Authors:  Jan Gryczynski; Robert P Schwartz; David S Salkever; Shannon Gwin Mitchell; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2011-08-06

8.  Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment.

Authors:  Sharon M Kelly; Kevin E Oʼgrady; Jerome H Jaffe; Devang Gandhi; Robert P Schwartz
Journal:  J Addict Med       Date:  2013 Mar-Apr       Impact factor: 3.702

9.  Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.

Authors:  Stacey C Sigmon; Andrew C Meyer; Bryce Hruska; Taylor Ochalek; Gail Rose; Gary J Badger; John R Brooklyn; Sarah H Heil; Stephen T Higgins; Brent A Moore; Robert P Schwartz
Journal:  Addict Behav       Date:  2015-07-29       Impact factor: 3.913

10.  Interim versus standard methadone treatment: a benefit-cost analysis.

Authors:  Robert P Schwartz; Pierre K Alexandre; Sharon M Kelly; Kevin E O'Grady; Jan Gryczynski; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2013-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.